Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 142 Records) |
Query Trace: KEAP1[original query] |
---|
EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers. BMC pulmonary medicine 2022 Sep 22 (1): 356. Li Zhenxiang, Zhou Qing, Wang Qi, Wang Haiyong, Yue Weimi |
Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC. JTO clinical and research reports 2022 Sep 3 (9): 100390. Cooper Alissa J, Muzikansky Alona, Lennerz Jochen, Narinesingh Farhaana, Mino-Kenudson Mari, Hung Yin P, Piotrowska Zofia, Dagogo-Jack Ibiayi, Sequist Lecia V, Gainor Justin F, Lin Jessica J, Heist Rebecca |
Association of Three SNPs Loci of Kelch-Like-ECH-Associated Protein 1 (Human) with Tuberculosis in Chinese Han Population. International journal of general medicine 2022 15 6365-6372. Wu Shouquan, Ding Xiaojuan, Yang Qianlan, Wang Minggui, He Jian-Qi |
Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer. Frontiers in oncology 2022 12 928605. He Kewen, Zhang Shaotong, Pang Jiaohui, Yin Jiani C, Mu Dianbin, Wang Jun, Ge Hong, Ma Jie, Yang Zhe, Zheng Xiaoli, Dong Lihua, Zhang Junli, Chang Pengyu, Li Li, Tang Shanshan, Bao Hua, Wu Xue, Wang Xiaonan, Shao Yang, Yu Jinming, Yuan Shuang |
Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer. Journal of thoracic disease 2022 7 14 (6): 1772-1783. Malhotra Jyoti, Ryan Brid, Patel Malini, Chan Nancy, Guo Yanxiang, Aisner Joseph, Jabbour Salma K, Pine Shar |
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP). Lung cancer (Amsterdam, Netherlands) 2022 Jun 170 114-121. Cordeiro de Lima Vladmir C, Corassa Marcelo, Saldanha Erick, Freitas Helano, Arrieta Oscar, Raez Luis, Samtani Suraj, Ramos Maritza, Rojas Carlos, Burotto Mauricio, Chamorro Diego F, Recondo Gonzalo, Ruiz-Patiño Alejandro, Más Luis, Zatarain-Barrón Lucia, Mejía Sergio, Nicolas Minata José, Martín Claudio, Bautista Blaquier Juan, Motta Guerrero Rodrigo, Aliaga-Macha Carlos, Carracedo Carlos, Ordóñez-Reyes Camila, Garcia-Robledo Juan Esteban, Corrales Luis, Sotelo Carolina, Ricaurte Luisa, Santoyo Nicolas, Cuello Mauricio, Jaller Elvira, Rodríguez July, Archila Pilar, Bermudez Maritza, Gamez Tatiana, Russo Alessandro, Viola Lucia, Malapelle Umberto, de Miguel Perez Diego, Rolfo Christian, Rosell Rafael, Cardona Andrés |
Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component. Frontiers in oncology 2022 12 12 989349. Li Peng, Liu Lu, Wang Dong, Yang Ronghua, Xuan Yunpeng, Han Yudong, Wang Jinglong, Guo Lijie, Zhang Liwen, Zhang Shanshan, Wang Yongj |
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology 2022 12 . Scalera S, Ricciuti B, Mazzotta M, Calonaci N, Alessi J V, Cipriani L, Bon G, Messina B, Lamberti G, Di Federico A, Pecci F, Milite S, Krasniqi E, Barba M, Vici P, Vecchione A, De Nicola F, Ciuffreda L, Goeman F, Fanciulli M, Buglioni S, Pescarmona E, Sharma B, Felt K D, Lindsay J, Rodig S J, De Maria R, Caravagna G, Cappuzzo F, Ciliberto G, Awad M M, Maugeri-Saccà |
Comprehensive analyses of genomic features and mutational signatures in adenosquamous carcinoma of the lung. Frontiers in oncology 2022 12 945843. Wang Hongbiao, Liu Jun, Zhu Sujuan, Miao Kun, Li Zhifeng, Qi Xiaofang, Huang Lujia, Guo Lijie, Wang Yan, Cai Yuyin, Lin Yingche |
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 10 . Paik Paul K, Fan Pang-Dian, Qeriqi Besnik, Namakydoust Azadeh, Daly Bobby, Ahn Linda, Kim Rachel, Plodkowski Andrew, Ni Ai, Chang Jason, Fanaroff Rachel, Ladanyi Marc, de Stanchina Elisa, Rudin Charles |
Probing Mutant KRAS, STK11, KEAP1 in NSCLC. Cancer discovery 2022 Aug OF1. Authors are not available |
Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations. Cancer research and treatment 2023 9 . Boram Song, Seok Hyun Lee, Jeong Hwan Park, Kyung Chul Mo |
GPX3 rs8177412 Polymorphism Modifies Risk of Upper Urothelial Tumors in Patients with Balkan Endemic Nephropathy. Medicina (Kaunas, Lithuania) 2023 8 59 (8): . Zana Radic Savic, Vesna Coric, Stojko Vidovic, Vanja Vidovic, Jelena Becarevic, Irina Milovac, Zorica Reljic, Bosa Mirjanic-Azaric, Ranko Skrbic, Radoslav Gajanin, Marija Matic, Tatjana Sim |
Coexisting Genomic Alterations in Risk Stratification of KRASG12C-Mutated Non-Small Cell Lung Cancer. Cancer discovery 2023 7 13 (7): 1513-1515. Sarina Z W Heng, Regina Hoo, Daniel S W T |
Evaluation of the Prognostic Value of Low-Frequency KRAS Mutation Detection in Circulating Tumor DNA of Patients with Metastatic Colorectal Cancer. Journal of personalized medicine 2023 7 13 (7): . Chien-Yu Lin, Ming-Yin Shen, William Tzu-Liang Chen, Chin-An Ya |
A core Nrf2 gene set defined through comprehensive transcriptomic analysis predicts drug resistance and poor multi-cancer prognosis. bioRxiv : the preprint server for biology 2023 5 . George Luo, Harshita Kumar, Kristin Aldridge, Stevie Rieger, Ethan Jiang, Ernest R Chan, Ahmed Soliman, Haider Mahdi, John J Letter |
Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting. BMC cancer 2023 4 23 (1): 352. Julian Cristina, Pal Navdeep, Gershon Anda, Evangelista Marie, Purkey Hans, Lambert Peter, Shi Zhen, Zhang Qi |
Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC. Cancer discovery 2023 4 . Negrao Marcelo V, Araujo Haniel A, Lamberti Giuseppe, Cooper Alissa J, Akhave Neal S, Zhou Teng, Delasos Lukas, Hicks J Kevin, Aldea Mihaela, Minuti Gabriele, Hines Jacobi, Aredo Jacqueline V, Dennis Michael J, Chakrabarti Turja, Scott Susan C, Bironzo Paolo, Scheffler Matthias, Christopoulos Petros, Stenzinger Albrecht, Riess Jonathan W, Kim So Yeon, Goldberg Sarah B, Li Mingjia, Wang Qi, Qing Yun, Ni Ying, Do Minh Truong, Lee Richard, Ricciuti Biagio, Alessi Joao Victor, Wang Jing, Resuli Blerina, Landi Lorenza, Tseng Shu-Chi, Nishino Mizuki, Digumarthy Subba R, Rinsurongkawong Waree, Rinsurongkawong Vadeerat, Vaporciyan Ara A, Blumenschein George R, Zhang Jianjun, Owen Dwight H, Blakely Collin M, Mountzios Giannis, Shu Catherine A, Bestvina Christine M, Garassino Marina Chiara, Marrone Kristen A, Gray Jhanelle E, Patel Sandip Pravin, Cummings Amy L, Wakelee Heather A, Wolf Juergen, Scagliotti Giorgio Vittorio, Cappuzzo Federico, Barlesi Fabrice, Patil Pradnya D, Drusbosky Leylah, Gibbons Don L, Meric-Bernstam Funda, Lee J Jack, Heymach John V, Hong David S, Heist Rebecca S, Awad Mark M, Skoulidis Ferdinand |
Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung Cancer. Internal medicine (Tokyo, Japan) 2023 3 . Sumii Masahiko, Namba Masashi, Tokumo Kentaro, Yamauchi Masami, Okamoto Wataru, Hattori Noboru, Sugiyama Kazuhi |
Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2023 2 . Rao Wen, Yang Lujie, Dai Nan, Zhang Liang, Liu Jie, Yang Bo, Li Mengxia, Shan Jinlu, Wang Qiushi, Wang Do |
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC. JTO clinical and research reports 2023 2 4 (1): 100431. Garassino Marina C, Gadgeel Shirish, Novello Silvia, Halmos Balazs, Felip Enriqueta, Speranza Giovanna, Hui Rina, Garon Edward B, Horinouchi Hidehito, Sugawara Shunichi, Rodriguez-Abreu Delvys, Reck Martin, Cristescu Razvan, Aurora-Garg Deepti, Loboda Andrey, Lunceford Jared, Kobie Julie, Ayers Mark, Piperdi Bilal, Pietanza M Catherine, Paz-Ares Lu |
Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel. Annals of medicine 2023 11 55 (2): 2280708. Kangpeng Yan, Li Niu, Boyu Wu, Chongwu He, Lei Deng, Chuan Chen, Zhangzhang Lan, Chao Lin, Weihua Kuang, Huihong Lin, Jun Zou, Wenyong Zhang, Zhiqiang L |
KEAP1/NRF2 Mutations in Stem Cells Define an Aggressive Subset of Head and Neck Cancer Patients Who Have a Poor Prognosis, Lung Metastasis, and Therapeutic Failure. Cancers 2023 10 15 (20): . Syed S Islam, Bedri Karakas, Abdelilah Aboussekhra, Abu Shadat M Nom |
A Transcriptomic Approach Outperforms Mutational Analysis to Identify KEAP1/NFE2L2 Pathway Activation in Patients With NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 10 18 (11): 1431-1433. Sara Hijazo-Pechero, Cristina Muñoz-Pinedo, Ernest Nad |
Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the NFE2L2/KEAP1 Polymorphisms in Regulating SARS-CoV-2 Infection. International journal of molecular sciences 2023 1 24 (1): . Soto María Elena, Fuentevilla-Álvarez Giovanny, Palacios-Chavarría Adrián, Vázquez Rafael Ricardo Valdez, Herrera-Bello Héctor, Moreno-Castañeda Lidia, Torres-Paz Yazmín Estela, González-Moyotl Nadia Janet, Pérez-Torres Idalia, Aisa-Alvarez Alfredo, Manzano-Pech Linaloe, Pérez-Torres Israel, Huesca-Gómez Claudia, Gamboa Ricar |
Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab. JAMA network open 2023 1 6 (1): e2249591. Lebow Emily S, Shepherd Annemarie, Eichholz Jordan E, Offin Michael, Gelblum Daphna Y, Wu Abraham J, Simone Charles B, Schoenfeld Adam J, Jones David R, Rimner Andreas, Chaft Jamie E, Riaz Nadeem, Gomez Daniel R, Shaverdian Nar |
Gestational Diabetes Mellitus (GDM), Hypothyroidism, and Gene Variants (Keap1 Rs11085735) in Patients with Preeclampsia. Reports of biochemistry & molecular biology 2023 1 11 (3): 493-501. Khadir Fatemeh, Rahimi Zohreh, Vaisi-Raygani Asad, Shakiba Ebrahim, Naseri Rozi |
Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC. Annals of oncology : official journal of the European Society for Medical Oncology 2023 1 . Mok T S K, Lopes G, Cho B C, Kowalski D M, Kasahara K, Wu Y-L, de Castro G, Turna H Z, Cristescu R, Aurora-Garg D, Loboda A, Lunceford J, Kobie J, Ayers M, Pietanza M C, Piperdi B, Herbst R |
Combining genomic biomarkers to guide immunotherapy in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 2 . Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voe |
Outcomes following KRAS inhibitor treatment in patients with KRAS-mutated solid tumors: A systematic review and meta-analysis. Pharmacological research 2024 1 200 107060. Qi-An Chen, Wei-Hao Lin, Xiao-Xiang Zhou, Zheng Cao, Xiao-Li Feng, Yi-Bo Gao, Jie |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: